Results 41 to 50 of about 4,320,983 (278)

The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective

PLoS ONE, 2018
Background The discussion on the use of bevacizumab is still ongoing and often doctors are deterred from using bevacizumab due to legal or political issues.
F. Asten, Charlotte T. J. Michels, C. Hoyng, Gert Jan Wilt, B., Jeroen B. Klevering, M. Rovers, J. Grutters   +7 more
semanticscholar   +1 more source

Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs. [PDF]

, 2013
Objectives To estimate the cost-effectiveness of remote monitoring strategies versus usual care for adults recently discharged after a heart failure (HF) exacerbation.
Al-Mohammad, A, Baalbaki, H, Bakhai, A, Brennan, A, Cleland, J, Cowie, MR, Gomersall, T, Pandor, A, Stevens, JW, Thokala, P, Wang, J, Wong, R   +11 more
core   +1 more source

Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis

Public Health Reviews, 2018
BackgroundScreening is an important part of preventive medicine. Ideally, screening tools identify patients early enough to provide treatment and avoid or reduce symptoms and other consequences, improving health outcomes of the population at a reasonable
N. Iragorri, E. Spackman
semanticscholar   +1 more source

An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis

PharmacoEconomics (Auckland), 2019
This paper provides an educational review covering the consideration of costs for cost-effectiveness analysis (CEA), summarising relevant methods and research from the published literature.
M. Franklin, J. Lomas, S. Walker, T. Young   +3 more
semanticscholar   +1 more source

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation [PDF]

, 2015
BACKGROUND: Liver biopsy is the reference standard for diagnosing the extent of fibrosis in chronic liver disease; however, it is invasive, with the potential for serious complications.
, , , , , , , , , , , , , , , , , , , , , , , Adams, Adams, Afdhal, Aguirre, Ahmad, Aithal, Al-Mohri, Anaparthy, Andersson, Angulo, Arena, Argo, Asbach, Ascher, Aube, Aube, Awaya, Barshop, Barton, Bataller, Beckebaum, Bedossa, Bejarano, Belfort, Bellentani, Ben Jazia, Bennett, Berg, Blomme, Bolondi, Bonkovsky, Boring, Borroni, Bourliere, Boursier, Boursier, Briggs, Brown, Brunetto, Buntinx, Burton, Cales, Cales, Cales, Calvaruso, Calvaruso, Calvaruso, Camma, Cardi, Cardoso, Carlson, Carrion, Carvalho-Filho, Castera, Castera, Castera, Castera, Castera, Castera, Ceriani, Chalasani, Chalasani, Chan, Chang, Chavez-Tapia, Cheinquer, Chen, Chen, Chen, Cheung, Cho, Cholongitas, Chong, Chou, Christensen, Chrysanthos, Cioni, Claxton, Cobbold, Colletta, Colli, Colli, Colombo, Corradi, Crespo, Cross, Crowley, Crowley, Curtis, da Silva, Dakin, Danila, David, Davis, de Franchis, De Freitas, De Jongh, de Ledinghen, De Ledinghen, Degos, Denzer, Detre, Di Bisceglie, Di Marco, Dinesen, Dixon, Dixon, Do, Donnan, Drummond, Dusheiko, D’Amico, D’Onofrio, Ekstedt, Esmat, Esteban, Fabris, Fahmy, Fattovich, Fattovich, Fattovich, Fattovich, Fattovich, Fattovich, Feldstein, Fenwick, Ferral, Fontaine, Fontana, Fontanges, Forestier, Forns, Fraquelli, Fried, Fried, Friedrich-Rust, Fujii, Fujimoto, Fung, Gaia, Gaia, Gaiani, Ganne-Carrie, Gara, Germani, Germani, Giannini, Gierblinski, Gobel, Goodman, Goyal, Grieve, Grishchenko, Guajardo-Salinas, Guechot, Guechot, Guha, Gui, Guo-Qiu, Guzelbulut, Hadziyannis, Halfon, Halfon, Halfon, Hall, Harada, Harrison, Haukeland, Hongbo, Hoofnagle, Hsieh, Hu, Huang, Hui, Huwart, Iacobellis, Ibrahim, Idilman, Imbert-Bismut, Imperiale, Isgro, Ishibashi, Islam, Iushchuk, Jacobson, Jacobson, Jacobson, Janssens, John-Baptiste, Jones, Jones, Joseph, Kalantari, Kamal, Kamphues, Kandemir, Kaneda, Kayadibi, Kelleher, Kelleher, Khan, Khosravi, Kilpe, Kim, Kim, Kim, Kim, Kim, Kim, Kim, Kim, Koda, Koizumi, Kwok, Lackner, Ladenheim, Ladero, Lai, Lampertico, Lau, Lavallard, Lavanchy, Lavine, Lawitz, Lee, Lee, Lee, Leroy, Leroy, Leroy, Lesmana, Levy, Lewin, Li, Liaw, Liaw, Lichtinghagen, Lieber, Lin, Liu, Liu, Liu, Liu, Liu, Liu, Loko, Longworth, Lupsor, Lupsor, Lupsor, Lutz, Lydatakis, Macaskill, Macias, Macias, Mahadeva, Mahady, Mahady, Mallet, Manns, Manns, Manousou, Manousou, Marcellin, Marcellin, Marcellin, Martinez, Martinez, McLernon, McPherson, McPherson, Melin, Miailhes, Mohamadnejad, Moreno-Otero, Morgan, Morikawa, Motosugi, Mueller, Mummadi, Murawaki, Musso, Myers, Myers, Nagata, Nahon, Naveau, Naveau, Nguyen-Khac, Nishiura, Nitta, Nojiri, Numminen, Nunes, Obara, Ogawa, Oliveira, Ong, Orlacchio, Orlacchio, Osakabe, O’Shea, Paggi, Pais, Palmeri, Papalavrentios, Parise, Park, Park, Park, Park, Park, Parkes, Patel, Patel, Pawitpok, Pereira, Petta, Pimentel, Pohl, Poordad, Poynard, Poynard, Poynard, Poynard, Prati, Promrat, Qian, Qiu, Qureshi, Raftopoulos, Rakoski, Ramachandran, Raszeja-Wyszomirska, Ratziu, Ratziu, Ratziu, Ratziua, Realdi, Reedy, Reitsma, Ronot, Rosenberg, Rossi, Rossini, Ruffillo, Rustogi, Saab, Said, Saitou, Sakugawa, Sancheztapias, Sandrasegaran, Santos, Sanvisens, Sanyal, Sanyal, Sanyal, Schiavon, Schiavon, Schneider, Schneider, Schuetz, Sebastian, Sebastiani, Sebastiani, Sebastiani, Sebastiani, Sene, Seto, Sharabash, Shastry, Shen, Shepherd, Shepherd, Shepherd, Sherman, Sheth, Shields, Shiffman, Shimada, Shin, Shinkins, Shiramizu, Siebert, Sinakos, Singal, Sirli, Snyder, Snyder, Sohn, Sohn, Sokucu, Sonnenberg, Sporea, Sporea, Sporea, Sporea, Sporea, Standish, Sterling, Stevenson, Stibbe, Sud, Sumida, Sumida, Suzuki, Sweeting, Takeda, Tassopoulos, Terjung, Testa, Thompson, Thompson, Thompson, Thompson Coon, Thompson Coon, Tillmann, Tome, Toniutto, Tran, Trang, Trifan, Trocme, Tsochatzis, Tsochatzis, Tsochatzis, Tsochatzis, Tsochatzis, Tural, Uygun, Vallet-Pichard, Valva, Vanbiervliet, Varaut, Veenstra, Veenstra, Venkatesh, Vernon, Verrill, Viana, Vigano, Viganò, Wai, Wang, Wang, Ware, Westin, Whiting, Whiting, Whiting, Whiting, Wilby, Wilck, Wilson, Wong, Wong, Wong, Wong, Wong, Wong, Wong, Wong, Woo, Wright, Wu, Xu, Yoneda, Yoneda, Younossi, Younossi, Yuen, Zaman, Zarski, Zarski, Zhang, Zhang, Zhang, Zhu, Zhu, Ziol   +503 more
core   +2 more sources

Cost-Effectiveness Analysis of Antihypertensive Therapy in Outpatient Hypertension Patients at Hospital X in Wajo Regency

Journal of Pharmacoeconomics and Pharmaceutical Management, 2023
Background Hypertension is a chronic disease that cannot be cured and can only be controlled but requires long-term treatment, even for life. The variety of antihypertensive treatments makes it necessary to adjust the choice of treatment not only in ...
Ida Adhayanti, Alya Rahmah Safitri, Ismail Ibrahim   +2 more
doaj   +1 more source

QALY league table of Iran: a practical method for better resource allocation

Cost Effectiveness and Resource Allocation, 2021
Background The limited health care resources cannot meet all the demands of the society. Thus, decision makers have to choose feasible interventions and reject the others. We aimed to collect and summarize the results of all cost utility analysis studies
Reza Hashempour, Behzad Raei, Majid Safaei Lari, Nasrin Abolhasanbeigi Gallezan, Ali AkbariSari   +4 more
doaj   +1 more source

A systematic review and economic evaluation of exercise referral schemes in primary care: a short report [PDF]

, 2015
Background - It is estimated that only 39% of men and 29% of women in England achieve the levels of physical activity that are recommended to protect health and prevent disease. One approach to addressing this problem has been the development of exercise
Anokye, Anokye, Anokye, Briggs, Brønnum-Hansen, Campbell, Crone, Curtis, Curtis, Damush, Deci, Department of Health, Dinan, Duda, Dugdill, Edmunds, Gidlow, Gonzalez, Gusi, Halbert, Hanson, Harrison, Harrison, Health Survey for England, Health Survey for England, Higgins, Hu, Hu, Hu, Isaacs, Jackson, James, Jamrozik, Jolly, Jones, Labour Research Department, Lamb, Leijon, Lord, Martin, Miller, Moore, Morgan, Morton, Murphy, Murphy, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), Office for National Statistics (ONS), Orrow, Pavey, Pavey, Preis, Prochaska, Roessler, Sorensen, Sorensen, Sorensen, Sowden, Sowden, Stevens, Taylor, Taylor, Taylor, Tobi, Tobi, US Department of Health and Human Services, Ward, Ward, Williams   +71 more
core   +3 more sources

Global bibliometric analysis of cost effectiveness analysis in healthcare research from 2013 to 2023

Cost Effectiveness and Resource Allocation
Background Cost-effectiveness analysis (CEA) has become a crucial technique in appraising the efficiency of healthcare interventions and resource allocation decisions.
Kemdi Lugard Okoroiwu, Henshaw Uchechi Okoroiwu, Love Ogochukwu Ude, Chidimma Odilia Ezuma, Emmanuel Ikechukwu Omeje   +4 more
doaj   +1 more source

Cost-Effectiveness Analysis Terapi Antibiotik Seftriakson Dan Sefotaksim Pada Pasien Tifoid Di RSUD Dr. M.M Dunda Limboto [PDF]

, 2017
Tifoid merupakan penyakit infeksi yang disebabkan oleh bakteri Salmonella typhi dan telah banyak menginfeksi masyarakat baik di perkotaan maupun pedesaan.
Tuloli, T. S. (Teti)
core